Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard B Fox

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonistsGregory A Gfesser, Henry Zhang, Jurgen Dinges, et al.
European Journal of Pharmacology|March 23, 2004
Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonistArthur A Hancock, Youssef L Bennani, Eugene N Bush, et al.
Biochemical Pharmacology|August 6, 2004
Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonistTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like propertiesTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
Neuroimage|September 18, 2012
Pharmacological modulation of brain activity in a preclinical model of osteoarthritisJaymin Upadhyay, Scott J Baker, Rajasimhan Rajagovindan, et al.
European Journal of Pharmacology|June 13, 2006
Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxietyAna M Basso, Natalie A Bratcher, Kelly B Gallagher, et al.
Translational Stroke Research|June 16, 2023
Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery OcclusionPeer B Jacobson, Andrea Mothe, Aharon Levy, et al.
Journal of Medicinal Chemistry|October 9, 2007
Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonistsRobert J Altenbach, Huaqing Liu, Patricia N Banfor, et al.
Biochemical Pharmacology|May 31, 2011
Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in ratsChang Z Zhu, Chih-Liang Chin, Nathan R Rustay, et al.
Alzheimer'S Research & Therapy|July 31, 2015
An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheterBrendan P Lucey, Celedon Gonzales, Ujjwas Das, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonistsGregory A Gfesser, Henry Zhang, Jurgen Dinges, et al.
European Journal of Pharmacology|March 23, 2004
Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonistArthur A Hancock, Youssef L Bennani, Eugene N Bush, et al.
Biochemical Pharmacology|August 6, 2004
Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonistTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like propertiesTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
Neuroimage|September 18, 2012
Pharmacological modulation of brain activity in a preclinical model of osteoarthritisJaymin Upadhyay, Scott J Baker, Rajasimhan Rajagovindan, et al.
European Journal of Pharmacology|June 13, 2006
Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxietyAna M Basso, Natalie A Bratcher, Kelly B Gallagher, et al.
Translational Stroke Research|June 16, 2023
Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery OcclusionPeer B Jacobson, Andrea Mothe, Aharon Levy, et al.
Journal of Medicinal Chemistry|October 9, 2007
Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonistsRobert J Altenbach, Huaqing Liu, Patricia N Banfor, et al.
Biochemical Pharmacology|May 31, 2011
Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in ratsChang Z Zhu, Chih-Liang Chin, Nathan R Rustay, et al.
Alzheimer'S Research & Therapy|July 31, 2015
An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheterBrendan P Lucey, Celedon Gonzales, Ujjwas Das, et al.
Pageof 7